In this report, we provide pharmacology data that demonstrates the muscle anabolic activity of the anti-myostatin antibody mRK35 and its clinical analog domagrozumab (PF-06252616) in rodents, including the mdx mouse model of DMD, and non-human primates. The gene discussed is MSTN; the disease is Duchenne muscular dystrophy.